XORTX Therapeutics Inc. (XRTX) stock
XRTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.06+0.02 (+1.92%)
Close on Nov 17, 2026Market cap $116.17KP/E –Yield –
XORTX Therapeutics EV/EBITDA
EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.
No ev/ebitda figures for XORTX Therapeutics
XORTX Therapeutics has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?